{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:07:11Z","timestamp":1792735631643,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.neuropharm.2011.02.015","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T08:55:51Z","timestamp":1298537751000},"page":"51-60","source":"Crossref","is-referenced-by-count":16,"title":["Cardiovascular effects of chronic treatment with a \u03b22-adrenoceptor agonist relieving neuropathic pain in mice"],"prefix":"10.1016","volume":"61","author":[{"given":"Nada","family":"Choucair-Jaafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Beetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gilsbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Waltisperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9","family":"Freund-Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Monassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Barrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.02.015_bib1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1378\/chest.123.6.1964","article-title":"Risk of\u00a0mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction","volume":"123","author":"Au","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/157488909789104794","article-title":"From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain","volume":"4","author":"Barrot","year":"2009","journal-title":"Recent Pat. C.N.S Drug Discov."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/fnl.09.82","article-title":"Antidepressant treatment of neuropathic pain: looking for the mechanism","volume":"5","author":"Barrot","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib5","doi-asserted-by":"crossref","first-page":"H2096","DOI":"10.1152\/ajpheart.00452.2009","article-title":"Type 1 diabetic cardiomyopathy in the Akita (Ins2WT\/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function","volume":"297","author":"Basu","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib6","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0091-6749(99)70270-8","article-title":"Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?","volume":"104","author":"Beasley","year":"1999","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cvr\/cvp251","article-title":"Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice","volume":"84","author":"Beetz","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(86)90434-4","article-title":"Myocardial ischemia during intravenous ritodrine treatment: is it so rare?","volume":"2","author":"Ben-Shlomo","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejpain.2008.01.010","article-title":"Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2007.06.016","article-title":"Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia","volume":"63","author":"Benbouzid","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejpain.2007.10.002","article-title":"Sciatic nerve cuffing in mice: a model of sustained neuropathic pain","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib12","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1067\/mob.2003.356","article-title":"Tocolytic treatment for the management of preterm labor: a review of the evidence","volume":"188","author":"Berkman","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s12265-010-9199-1","article-title":"Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1","volume":"3","author":"Bhavsar","year":"2010","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejpain.2009.11.014","article-title":"Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia","volume":"14","author":"Bohren","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0092-8674(01)00629-8","article-title":"DREAM is a critical transcriptional repressor for pain modulation","volume":"108","author":"Cheng","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1476-5381.2009.00510.x","article-title":"Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment","volume":"158","author":"Choucair-Jaafar","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hlc.2008.09.010","article-title":"Can \u03b2 agonists cause dilated cardiomyopathy?","volume":"18","author":"Choudhary","year":"2009","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib18","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/ALN.0b013e3181d40399","article-title":"Is there a place for \u03b2-mimetics in clinical management of neuropathic pain? Salbutamol therapy in six cases","volume":"112","author":"Cok","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib19","first-page":"528","article-title":"Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study","volume":"142","author":"Coughlin","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/CS19990069","article-title":"Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats","volume":"98","author":"Duncan","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00007611-199005000-00007","article-title":"Electrocardiographic abnormalities during ritodrine administration","volume":"83","author":"Faidley","year":"1990","journal-title":"South Med. J."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00101-009-1536-x","article-title":"Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation: preclinical differential diagnostic and emergency treatment","volume":"58","author":"Friege","year":"2009","journal-title":"Anaesthesist"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib25","series-title":"Current Clinical Practice: Allergic Disease: Diagnosis and Treatment","first-page":"335","article-title":"\u03b2-adrenergic agonists","author":"Furukawa","year":"2007"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.060146","article-title":"Neuropathic pain: a practical guide for the clinician","volume":"175","author":"Gilron","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib67","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cardiores.2007.05.017","article-title":"Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction","volume":"75","author":"Gilsbach","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2144\/000112052","article-title":"Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data","volume":"40","author":"Gilsbach","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2008.03.100","article-title":"Connective tissue growth factor induces cardiac hypertrophy through Akt signaling","volume":"370","author":"Hayata","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib29","first-page":"31","article-title":"Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart","volume":"60","author":"Heather","year":"2009","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","article-title":"Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy","volume":"104","author":"Jaffr\u00e9","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.ejcts.2006.02.014","article-title":"Assessment of left ventricular ejection fraction may invalidate the reliability of EuroSCORE","volume":"29","author":"Jakobsen","year":"2006","journal-title":"Eur. J. CardioThorac. Surg."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0773.1986.tb00080.x","article-title":"Further studies on the cardiomegaly induced by beta-adrenoceptor agonists","volume":"58","author":"Jeppsson","year":"1986","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib33","series-title":"The Role of Beta Receptor Agonist Therapy in Asthma Mortality","first-page":"163","article-title":"The acute unwanted effects of beta2 receptor agonist therapy","author":"Kendall","year":"1993"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib34","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9378(93)90479-3","article-title":"Peripartum heart failure associated with prolonged tocolytic therapy","volume":"168","author":"Lampert","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002040050059","article-title":"A\u00a0review of the toxicology of salbutamol (albuterol)","volume":"68","author":"Libretto","year":"1994","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib37","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.101.14.1707","article-title":"Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level","volume":"101","author":"Liggett","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib38","first-page":"483","article-title":"Antidepressants and antiepileptic drugs for chronic non-cancer pain","volume":"71","author":"Maizels","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/cs0840651","article-title":"Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients","volume":"84","author":"Maltin","year":"1993","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib40","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.transproceed.2009.05.040","article-title":"Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report","volume":"41","author":"Mano","year":"2009","journal-title":"Transplant Proc."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/thx.53.7.558","article-title":"Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists","volume":"53","author":"Martin","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mico","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/HYPERTENSIONAHA.107.105551","article-title":"Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice","volume":"52","author":"Monassier","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib44","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/jmcc.2000.1332","article-title":"Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart","volume":"33","author":"Morisco","year":"2001","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3959(95)00077-1","article-title":"Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations","volume":"64","author":"Mosconi","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10741-007-9007-4","article-title":"Cardiac hypertrophy induced by sustained \u03b2-adrenoceptor activation: pathophysiological aspects","volume":"12","author":"Osadchii","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib49","first-page":"357","article-title":"The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep","volume":"75","author":"Pack","year":"1994","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib50","first-page":"I77","article-title":"Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failure","volume":"82","author":"Packer","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(99)00085-8","article-title":"Nerve constriction in the rat: model of neuropathic, surgical and central pain","volume":"83","author":"Pitcher","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib52","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","article-title":"Metabolic gene expression in fetal and failing human heart","volume":"104","author":"Razeghi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2008.06.003","article-title":"The potential and the pitfalls of \u03b2-adrenoceptor agonists for the management of skeletal muscle wasting","volume":"120","author":"Ryall","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib54","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the\u00a0treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1440-1754.1996.tb00961.x","article-title":"Hypokalaemia following nebulized salbutamol in children with acute attack of bronchial asthma","volume":"32","author":"Singhi","year":"1996","journal-title":"J.\u00a0Paediatr. Child Health"},{"key":"10.1016\/j.neuropharm.2011.02.015_bib57","doi-asserted-by":"crossref","first-page":"H1468","DOI":"10.1152\/ajpheart.00624.2004","article-title":"Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle","volume":"288","author":"Soppa","year":"2005","journal-title":"Am. J. Physiol. Heart Cir. Physiol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib58","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.athoracsur.2009.07.038","article-title":"Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart","volume":"88","author":"Stansfield","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib59","first-page":"361","article-title":"Tocolytic treatment for the management of preterm labour: a systematic review","volume":"47","author":"Tan","year":"2006","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI108522","article-title":"Hemodynamic determinants of the time-course of fall in canine left ventricular pressure","volume":"58","author":"Weiss","year":"1976","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0008-6363(97)00190-9","article-title":"Clenbuterol induces hypertrophy with normal functional, morphological and molecular features","volume":"37","author":"Wong","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.21542","article-title":"beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain","volume":"65","author":"Yalcin","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib64","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.11.003","article-title":"Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain","volume":"33","author":"Yalcin","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib65","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2009.10.008","article-title":"Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain","volume":"221","author":"Yalcin","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.02.015_bib66","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1099-0496(200006)29:6<424::AID-PPUL2>3.0.CO;2-2","article-title":"One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group","volume":"29","author":"Zarkovic","year":"2000","journal-title":"Pediatr. Pulmonol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T10:26:43Z","timestamp":1543919203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":67,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0028390811000852"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}